Item 3.02 Unregistered Sales of Equity Securities.
Sales of Preferred Shares
Between July 26, 2022 and August 10, 2022, the Company entered into subscription
agreements with certain accredited investors pursuant to which the Company sold
an aggregate of 3.8 shares of the Company's Series Y preferred stock for an
aggregate purchase price of $380,000. The Company also issued an aggregate of
3,040,000 warrants to these investors.
In connection with the foregoing, the Company relied upon the exemption from
registration provided under Section 4(a)(2) under the Securities Act for
transactions not involving a public offering.
Conversion of Notes
On July 29, 2022, holders of convertible promissory notes converted an aggregate
principal and interest amount of $150,912 into an aggregate of 27,438,605 shares
of the Company's common stock.
In connection with the foregoing, the Company relied upon the exemption from
registration provided under Section 4(a)(2) under the Securities Act for
transactions not involving a public offering.
Conversion of Preferred Shares
On August 1, 2022, holders of the Company's Series R preferred stock converted
an aggregate of 1 Series R shares into an aggregate of 106,496 shares of the
Company's common stock.
On August 5, 2022, holders of the Company's Series T preferred stock converted
an aggregate of 268 Series T shares into an aggregate of 29,777,778 shares of
the Company's common stock.
On August 5, 2022, holders of the Company's Series Y preferred stock converted
an aggregate of 6.8 Series Y shares into an aggregate of 46,370,347 shares of
the Company's common stock.
On August 8, 2022, holders of the Company's Series U preferred stock converted
an aggregate of 25 Series U shares into an aggregate of 3,028,099 shares,
including make-good shares, of the Company's common stock.
In connection with the foregoing, the Company relied upon the exemption from
registration provided under Section 4(a)(2) under the Securities Act for
transactions not involving a public offering.
Restricted Stock Grant Agreement Issuances
On August 8, 2022, per electing and qualifying for the Restricted Stock Grant
Agreement alternate vesting schedule, the Company issued to Mr. T. Riggs
Eckelberry and one consultant an aggregate of 1,023,192 shares of the Company's
common stock.
In connection with the foregoing, the Company relied upon the exemption from
registration provided under Section 4(a)(2) under the Securities Act for
transactions not involving a public offering.
Issuance of Common Stock
Between July 29, 2022 and August 10, 2022, the Company issued to consultants an
aggregate of 2,165,009 shares of the Company's common stock for services.
In connection with the foregoing, the Company relied upon the exemption from
registration provided under Section 4(a)(2) under the Securities Act for
transactions not involving a public offering.
1
© Edgar Online, source Glimpses